Defeating AIDS—advancing global health

P Piot, SSA Karim, R Hecht, H Legido-Quigley, K Buse… - The Lancet, 2015 - thelancet.com
Executive summary After more than a decade of major achievements, the AIDS response is
at a crucial juncture, both in terms of its immediate trajectory and its sustainability, as well as …

Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

R Granich, S Crowley, M Vitoria, C Smyth… - Current Opinion in …, 2010 - journals.lww.com
HAART has considerable treatment and prevention benefits and it needs to be considered
as a key element of combination prevention. To explore HAART as an effective prevention …

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–7

DM Eddy, W Hollingworth, JJ Caro… - Medical Decision …, 2012 - journals.sagepub.com
Trust and confidence are critical to the success of health care models. There are two main
methods for achieving this: transparency (people can see how the model is built) and …

Early versus standard antiretroviral therapy for HIV-infected adults in Haiti

P Severe, MA Jean Juste, A Ambroise… - … England Journal of …, 2010 - Mass Medical Soc
Background For adults with human immunodeficiency virus (HIV) infection who have CD4+
T-cell counts that are greater than 200 and less than 350 per cubic millimeter and who live in …

Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start HIV …

DB Meya, YC Manabe, B Castelnuovo… - Clinical Infectious …, 2010 - academic.oup.com
Background. Cryptococcal meningitis (CM) remains a common AIDS-defining illness in
Africa and Asia. Subclinical cryptococcal antigenemia is frequently unmasked with …

Critical care in resource-poor settings: lessons learned and future directions

ED Riviello, S Letchford, L Achieng… - Critical care …, 2011 - journals.lww.com
Critical care must meet a further challenge, in that it has often been deemed inappropriate or
at least of lower priority than prevention and primary care. This lack of prioritization is not …

Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050

R Granich, JG Kahn, R Bennett, CB Holmes, N Garg… - PloS one, 2012 - journals.plos.org
Background Antiretroviral Treatment (ART) significantly reduces HIV transmission. We
conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa …

Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults

N Siegfried, OA Uthman… - Cochrane Database of …, 2010 - cochranelibrary.com
Background According to consensus, initiation of therapy is best based on CD4 cell count, a
marker of immune status, rather than on viral load, a marker of virologic replication. For …

Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review

KM Stadeli, DD Richman - Antiviral therapy, 2013 - journals.sagepub.com
Background The increasing availability of antiretroviral therapy (ART) has improved survival
and quality of life for many infected with HIV, but can also engender drug resistance. This …

HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?

EP Hyle, K Naidoo, AE Su, WM El-Sadr… - JAIDS Journal of …, 2014 - journals.lww.com
Unprecedented investments in health systems in low-and middle-income countries (LMICs)
have resulted in more than 8 million individuals on antiretroviral therapy. Such individuals …